Revlimid lenalidomide: Additional Phase III data

Additional data from 370 evaluable patients in a Phase III trial showed that following induction treatment with Revlimid plus low-dose dexamethasone resulted in at least a partial

Read the full 271 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE